Literature DB >> 3923285

[Models and perspectives of pancreas transplantation in the rat. II. Course of rejection of pancreaticoduodenal transplants of various histoincompatibility and the effect of temporary therapy with cyclosporin (Sandimmun)].

W Timmermann, T Schang, A Thiede.   

Abstract

Pancreaticoduodenal grafts were transplanted into streptozocin-induced diabetic recipients. Recipients of syngeneic grafts survived long term with functioning grafts. To investigate the rejection reaction in pancreaticoduodenal allografts, the organs were grafted in an MHC compatible but non-MHC incompatible strain combination (AS----LEW) and in a combination that is both MHC and non-MHC incompatible (DA----LEW). The functioning times were 12.4 +/- 4.0 days in the AS----LEW group and 8.2 +/- 0.6 days in the DA----LEW group. A histologic study of the course of the rejection process showed that first the exocrine portion of the grafts, then the endocrine tissue, and finally the duodenum was destroyed. After the recipients of allografts were treated with an oral dose of 15 mg/kg/day Ciclosporin (Sandimmun) for 14 days p.op., the functioning times of the grafts increased to 47.5 +/- 14.4 days in the AS-LEW group and 26.0 +/- 0.5 days in the DA-LEW group. Histologic investigations showed that during the period in which Ciclosporin was given, only perivascular round cell infiltrates appeared with no visible destruction of the graft. After discontinuation of the medication basically the same histologic alterations occurred as in untreated allografts, however with a delay.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923285     DOI: 10.1007/bf01262497

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  11 in total

1.  Pancreaticoduodenal transplantation in the rat.

Authors:  S Lee; K S Tung; H Koopmans; J G Chandler; M J Orloff
Journal:  Transplantation       Date:  1972-04       Impact factor: 4.939

2.  Allografts in genetically defined rats: difference in survival between kidney and skin.

Authors:  E White; W H Hildemann
Journal:  Science       Date:  1968-12-13       Impact factor: 47.728

3.  Reactivity of pancreas islet cells with antisera of known specificity.

Authors:  K Ulrichs; T Schang; R Keller; W Müller-Ruchholtz
Journal:  Transplant Proc       Date:  1984-06       Impact factor: 1.066

4.  Cyclosporin A prolongation of segmental pancreatic and islet allograft function in rats.

Authors:  J J Rynasiewicz; D E Sutherland; K Kawahara; P Gorecki; J S Najarian
Journal:  Transplant Proc       Date:  1980-06       Impact factor: 1.066

5.  The effect of cyclosporin A on experimental pancreas allografts in the rat.

Authors:  J F Garvey; P McShane; M D Poole; P R Millard; P J Morris
Journal:  Transplant Proc       Date:  1980-06       Impact factor: 1.066

Review 6.  Immunogenicity of foreign tissues.

Authors:  K J Lafferty
Journal:  Transplantation       Date:  1980-03       Impact factor: 4.939

7.  Effect of warm ischemia on segmental pancreas transplantation in the rat.

Authors:  J A Schulak; W A Franklin; F P Stuart; C R Reckard
Journal:  Transplantation       Date:  1983-01       Impact factor: 4.939

8.  [Action of cyclosporin A and cytimun on the survival time of accessory heart transplants (author's transl)].

Authors:  W Timmermann; R Y Calne; D J White; D White; A Thiede
Journal:  Chir Forum Exp Klin Forsch       Date:  1980

9.  Studies on the immunosuppressive properties of cyclosporin a in rats receiving renal allografts.

Authors:  W P Homan; J W Fabre; K A Williams; P R Millard; P J Morris
Journal:  Transplantation       Date:  1980-05       Impact factor: 4.939

10.  Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells.

Authors:  R I Lechler; J R Batchelor
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

View more
  1 in total

1.  Experimental rat pancreas transplant: surgical technique and immunological considerations.

Authors:  S Ohtsuka; I Yokoyama; S Hayashi; T Haba; H Takagi
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.